These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14492395)

  • 1. Symposium on clinical drug evaluation and human pharmacology. XII. Assessment of antianginal agents.
    RINZLER SH
    Clin Pharmacol Ther; 1962; 3():505-9. PubMed ID: 14492395
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical pharmacology of antianginal drugs.
    MODELL W
    Clin Pharmacol Ther; 1962; 3():97-108. PubMed ID: 14474953
    [No Abstract]   [Full Text] [Related]  

  • 3. Assay of antianginal agents; the rapport period.
    COLE SL; KAYE H; GRIFFITH GC
    J Am Med Assoc; 1958 Sep; 168(3):275-7. PubMed ID: 13575155
    [No Abstract]   [Full Text] [Related]  

  • 4. [The treatment of angina pectoris: clinical and instrumental evaluation of an anti-anginal drug combination].
    MALFANTI PL
    Minerva Med; 1960 Oct; 51():3578-85. PubMed ID: 13765767
    [No Abstract]   [Full Text] [Related]  

  • 5. EXPERIMENTAL APPROACHES TO THE DEVELOPMENT OF ANTIANGINAL DRUGS.
    WINBURY MM
    Adv Pharmacol (1962); 1964; 3():1-82. PubMed ID: 14236560
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of drug therapy of angina pectoris.
    PORDY L; CHESKY K
    Trans Am Coll Cardiol; 1952; 2():128. PubMed ID: 13049502
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of antianginal effects of running pulse magnetic field and drug therapy on the physical working capacity and hemodynamics in patients with stable angina pectoris].
    Orlov LL; Makoeva LD; Glezer MG; Titov SIu; Arzhanenko OM; Margarian AG; Musev VA; Memetov KA; Belinskaia TF
    Kardiologiia; 1992 Feb; 32(2):23-6. PubMed ID: 1527930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of angina pectoris: evaluation of anti-anginal agents and procedures.
    COLE SL
    Dis Chest; 1958 Sep; 34(3):330-4. PubMed ID: 13574042
    [No Abstract]   [Full Text] [Related]  

  • 9. An investigation of the pharmacological treatment of angina pectoris.
    GANZ V; FRONEK A; HAMMER J
    Rev Czech Med; 1962; 8():137-42. PubMed ID: 13896706
    [No Abstract]   [Full Text] [Related]  

  • 10. Symposium on coronary dilator drugs.
    EDDLEMAN EE; FRIEDMAN B; HARRISON TR; HEFNER LL; REEVES TJ
    Circulation; 1957 Jan; 15(1):111-7. PubMed ID: 13396937
    [No Abstract]   [Full Text] [Related]  

  • 11. A systematic approach to refractory angina.
    Khan SN; Dutka DP
    Curr Opin Support Palliat Care; 2008 Dec; 2(4):247-51. PubMed ID: 19060562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of stable angina pectoris.
    Palaniswamy C; Aronow WS
    Am J Ther; 2011 Sep; 18(5):e138-52. PubMed ID: 20861717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable angina pectoris: current medical treatment.
    Siama K; Tousoulis D; Papageorgiou N; Siasos G; Tsiamis E; Bakogiannis C; Briasoulis A; Androulakis E; Tentolouris K; Stefanadis C
    Curr Pharm Des; 2013; 19(9):1569-80. PubMed ID: 23016717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term benefits and limitations of combined antianginal drug therapy in elderly patients with symptomatic chronic coronary artery disease.
    Bonetti PO; Kaiser C; Zellweger MJ; Grize L; Erne P; Schoenenberger RA; Pfisterer ME;
    J Cardiovasc Pharmacol Ther; 2005 Mar; 10(1):29-37. PubMed ID: 15821836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy of basic antianginal preparations in patients with stenocardia after the aortocoronary bypass operation].
    Vykhovaniuk IV
    Ter Arkh; 1991; 63(8):41-5. PubMed ID: 1792615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of antianginal preparations in ischemic heart disease depending on the duration of the courses of treatment].
    Progonnaia VV
    Vrach Delo; 1988 Jul; (7):29-31. PubMed ID: 3188458
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of Persistent Angina After Myocardial Infarction Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study.
    Fanaroff AC; Kaltenbach LA; Peterson ED; Hess CN; Cohen DJ; Fonarow GC; Wang TY
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29051217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental and early investigational drugs for angina pectoris.
    Elgendy IY; Winchester DE; Pepine CJ
    Expert Opin Investig Drugs; 2016 Dec; 25(12):1413-1421. PubMed ID: 27791405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evidence-based optimal treatment strategy of patients with angina pectoris].
    Jánosi A
    Orv Hetil; 2008 Feb; 149(7):293-8. PubMed ID: 18258559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical pharmacology of antianginal agents].
    Metelitsa VI; Martsevich SIu; Kokurina EV; Bochkareva EV; Kozyreva MP; Kutishenko NP; Rumiantsev DO; Blagodatskikh SV; Vodop'ianova RS; Kukushkin SK
    Eksp Klin Farmakol; 1995; 58(2):3-7. PubMed ID: 7773085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.